Why a competitive process beats the first offer
The first offer is almost never the best offer. When a breakthrough molecule reaches the market, the inventor is usually negotiating alone, against teams who do deals every day. The temptation is to take the first credible term sheet that appears. That is how value quietly leaks away.
A disciplined, competitive process changes that. The right partners approached in parallel, under the right diligence framework, turns a single bid into a real market for the asset. It preserves tension, it surfaces the terms the science actually deserves, and it lets the inventor stay focused on the work rather than the deal.
That process is the whole job at Modulus Biotech. We represent scientists exclusively and run it on their behalf.
Have a program worth de-risking?
See how we work with inventors →Filling a pipeline gap?
Talk to us →